ScienceGate Book Chapters

JOURNAL ARTICLE

Orphan designation: Exendin (9-39), Treatment of congenital hyperinsulinism

Case Medical Research

Year: 2020 Journal: Case Medical Research Publisher: Case Journals

DOI: 10.31525/cmr-294b065

Get Full-Text PDF Get Analytical Report

Keywords:

Congenital hyperinsulinism Hyperinsulinism Medicine Pediatrics Internal medicine Endocrinology Insulin

Metrics

0

Cited By

0.00

FWCI (Field Weighted Citation Impact)

0

Refs

0.32

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Hyperglycemia and glycemic control in critically ill and hospitalized patients

Health Sciences → Medicine → Endocrinology, Diabetes and Metabolism

Related Documents

JOURNAL ARTICLE

Orphan designation: Exendin (9-39), Treatment of noninsulinoma pancreatogenous hypoglycaemia syndrome

Kernel Networks Inc.

Journal: Case Medical Research Year: 2019

JOURNAL ARTICLE

Orphan designation: Glucagon, Treatment of congenital hyperinsulinism

Case Medical Research

Journal: Case Medical Research Year: 2019

JOURNAL ARTICLE

Orphan designation: Glucagon, Treatment of congenital hyperinsulinism

Kernel Networks Inc.

Journal: Case Medical Research Year: 2019

JOURNAL ARTICLE

Orphan designation: Recombinant human monoclonal antibody to insulin receptor, Treatment of congenital hyperinsulinism

Case Medical Research

Journal: Case Medical Research Year: 2019

JOURNAL ARTICLE

Orphan designation: Recombinant human monoclonal antibody to insulin receptor, Treatment of congenital hyperinsulinism

Kernel Networks Inc.

Journal: Case Medical Research Year: 2019